Menu
Log In
Vol 2_November 25.2025_Newsletter_Healthcare Alliance
Search for
Switch skin
Home
About Us
News
Local Dynamics
Global Trends
M&A
Solutions
Business Consulting
Recruitment Solutions
Capability Development
Health Education
Careers
Videos
Thought Leadership
Market Trends
Capability Development
Corporate Wellness
Knowledge
Thought Leadership
Market Trends
Capability Development
Corporate Wellness
Newsletter
Contact
Contact Us
FAQS
Search for
Saturday, December 6 2025
Breaking News
European Authorities Clear Novel Autoimmune Therapy for Myasthenia Gravis
Eli Lilly Secures Experimental Cancer Therapy from Scorpion in Up-to-$2.5 Billion Deal
📰 Novartis Acquires Anthos Therapeutics for Up to $3.1 Billion to Boost Cardiovascular Pipeline
Merck Finalizes $3.4 Billion Acquisition, Enhancing Rare Tumor Portfolio
Roche Commits $3.5 Billion to Bolster MASH Portfolio via 89bio Acquisition
Novo Nordisk Secures Key MASH Therapy in $5.2 Billion Strategic Deal
Merck Finalizes $10 Billion Acquisition of Verona Pharma with No Competing Bids
Johnson & Johnson Expands Neuroscience Portfolio with $14.6 Billion Acquisition
Pharmaceutical Giant Finalizes Acquisition of Obesity Drug Developer
Vetter Managing Director to Retire Following Over Three Decades of Service
Facebook
LinkedIn
Log In
Sidebar
Switch skin
Vol 2_November 25.2025_Newsletter_Healthcare Alliance
Back to top button
Close
Search for
Close
Search for
Close
Log In
Forget?
Remember me
Log In
